Drug Chatter -- Tracking biopharma stock chatter

Profile for Concert Pharmaceuticals, Inc. (CNCE)

« Back to company index

CNCE Chatter Timeline

Stock Ticker for CNCE

Most Active Tweeters for CNCE

UserTweets
@ZolmaxNews 6
@intercooleronli 6
@TickerReport 6
@CFinancialNews 6
@midetimes 4

Recent Tweets for CNCE

WKRBNews @WKRBNews
Concert Pharmaceuticals, Inc. $CNCE Cut to “Hold” at Zacks Investment Research https://t.co/6AgPslgmK1
September 25th 2017, 8:09am
dailypoliticaln @dailypoliticaln
Concert Pharmaceuticals, Inc. $CNCE Cut to “Hold” at Zacks Investment Research https://t.co/xBYat7u4Gr
September 25th 2017, 8:09am
dailymailtimes @dailymailtimes
Concert Pharmaceuticals, Inc. $CNCE Cut to “Hold” at Zacks Investment Research https://t.co/4dbRkMPObj
September 25th 2017, 8:09am
midetimes @midetimes
Concert Pharmaceuticals, Inc. $CNCE Cut to “Hold” at Zacks Investment Research https://t.co/PdS1mh17on
September 25th 2017, 8:09am
TheMarketsDaily @TheMarketsDaily
Senzar Asset Management LLC Has $5.75 Million Holdings in Concert Pharmaceuticals, Inc. $CNCE https://t.co/wHTOXffQdD
September 24th 2017, 11:09am
TranscriptDaily @TranscriptDaily
Concert Pharmaceuticals, Inc. $CNCE Rating Lowered to Hold at Zacks Investment Research https://t.co/u86jFYkyQJ
September 24th 2017, 4:09am
SPNewsAnalysis @SPNewsAnalysis
Concert Pharmaceuticals, Inc. $CNCE Downgraded by Zacks Investment Research to “Hold” https://t.co/zawoi7xeL1
September 23rd 2017, 1:09pm
dakotafinancial @dakotafinancial
Zacks Investment Research Downgrades Concert Pharmaceuticals, Inc. $CNCE to Hold https://t.co/rE4PYLwaED
September 22nd 2017, 6:09pm
intercooleronli @intercooleronli
Zacks Investment Research Downgrades Concert Pharmaceuticals, Inc. $CNCE to Hold https://t.co/83968ARa5K
September 22nd 2017, 6:09pm
CFinancialNews @CFinancialNews
Zacks Investment Research Downgrades Concert Pharmaceuticals, Inc. $CNCE to Hold https://t.co/T2FSX8Ob17
September 22nd 2017, 6:09pm
RatingsNetwork @RatingsNetwork
Concert Pharmaceuticals downgraded by Zacks Investment Research to hold. https://t.co/MipasJcriJ $CNCE #CNCE
September 22nd 2017, 6:09pm
SleekMoneycom @SleekMoneycom
Concert Pharmaceuticals $CNCE and Its Rivals Head to Head Survey https://t.co/HSiIWOkySq
September 21st 2017, 7:09pm
IRAMarketReport @IRAMarketReport
Concert Pharmaceuticals $CNCE and Its Rivals Head to Head Survey https://t.co/XIAIsCPh2S
September 21st 2017, 7:09pm
chaffeybreeze @chaffeybreeze
Concert Pharmaceuticals $CNCE and Its Rivals Head to Head Survey https://t.co/C9CyWtYbye
September 21st 2017, 7:09pm
ZolmaxNews @ZolmaxNews
Insider Selling: Concert Pharmaceuticals, Inc. $CNCE Insider Sells $50,785.00 in Stock https://t.co/tZz99SEhgx
September 21st 2017, 10:09am
dakotafinancial @dakotafinancial
HC Wainwright Reaffirms “Buy” Rating for Concert Pharmaceuticals, Inc. $CNCE https://t.co/fuZ5nGqUbr
September 21st 2017, 7:09am
emq_news @emq_news
Concert Pharmaceuticals, Inc. $CNCE Upgraded at Zacks Investment Research https://t.co/qi8LoVQwMd
September 21st 2017, 5:09am
CFinancialNews @CFinancialNews
Critical Review: Matinas BioPharma Holdings $MTNB and Concert Pharmaceuticals $CNCE https://t.co/N84c3WokQc
September 20th 2017, 10:09am
intercooleronli @intercooleronli
Critical Review: Matinas BioPharma Holdings $MTNB and Concert Pharmaceuticals $CNCE https://t.co/S4JcFjjdp8
September 20th 2017, 10:09am
TheMarketsDaily @TheMarketsDaily
Critical Review: Matinas BioPharma Holdings $MTNB and Concert Pharmaceuticals $CNCE https://t.co/dfDnx6kS7N
September 20th 2017, 10:09am
WatchlistN @WatchlistN
Ryan Lynch Sells 3,500 Shares of Concert Pharmaceuticals, Inc. $CNCE Stock https://t.co/a7LxBBczwj
September 20th 2017, 5:09am
IRAMarketReport @IRAMarketReport
HC Wainwright Reiterates Buy Rating for Concert Pharmaceuticals, Inc. $CNCE https://t.co/7c8QkkqsVy
September 20th 2017, 5:09am
chaffeybreeze @chaffeybreeze
HC Wainwright Reiterates Buy Rating for Concert Pharmaceuticals, Inc. $CNCE https://t.co/Gl5vbYby6p
September 20th 2017, 5:09am
ZolmaxNews @ZolmaxNews
Concert Pharmaceuticals, Inc. $CNCE Stock Rating Upgraded by Zacks Investment Research https://t.co/pWF2RMgkqh
September 20th 2017, 4:09am
WatchlistN @WatchlistN
Reviewing Concert Pharmaceuticals $CNCE and Its Peers https://t.co/Bt5XP2wYpb
September 19th 2017, 12:09pm
WKRBNews @WKRBNews
Concert Pharmaceuticals, Inc. $CNCE Upgraded by Zacks Investment Research to “Buy” https://t.co/ezDb9TAFum
September 19th 2017, 9:09am
dailymailtimes @dailymailtimes
Concert Pharmaceuticals, Inc. $CNCE Upgraded by Zacks Investment Research to “Buy” https://t.co/LZR4ZclqX8
September 19th 2017, 9:09am
dailypoliticaln @dailypoliticaln
Concert Pharmaceuticals, Inc. $CNCE Upgraded by Zacks Investment Research to “Buy” https://t.co/H9K7HAUcl9
September 19th 2017, 9:09am
midetimes @midetimes
Concert Pharmaceuticals, Inc. $CNCE Upgraded by Zacks Investment Research to “Buy” https://t.co/RSvtESJ3xk
September 19th 2017, 9:09am
TickerReport @TickerReport
Concert Pharmaceuticals, Inc. $CNCE Receives Buy Rating from HC Wainwright https://t.co/PvvQTG5uyt
September 19th 2017, 9:09am
emq_news @emq_news
Concert Pharmaceuticals, Inc. $CNCE Receives Buy Rating from HC Wainwright https://t.co/Eg2gjEZmuO
September 19th 2017, 9:09am
TickerReport @TickerReport
Concert Pharmaceuticals, Inc. $CNCE Receives Buy Rating from HC Wainwright https://t.co/TEuIARRHmY
September 19th 2017, 9:09am
TickerReport @TickerReport
Concert Pharmaceuticals, Inc. $CNCE Insider Ryan Lynch Sells 3,500 Shares https://t.co/kI6lS6jyrb
September 19th 2017, 6:09am
emq_news @emq_news
Concert Pharmaceuticals, Inc. $CNCE Insider Ryan Lynch Sells 3,500 Shares https://t.co/cekkxd2FyS
September 19th 2017, 6:09am
TickerReport @TickerReport
Concert Pharmaceuticals, Inc. $CNCE Insider Ryan Lynch Sells 3,500 Shares https://t.co/m7wc5E5D3l
September 19th 2017, 6:09am
TickerReport @TickerReport
Concert Pharmaceuticals, Inc. $CNCE Stock Rating Lowered by Zacks Investment Research https://t.co/IXwQtIStpf
September 19th 2017, 5:09am
TickerReport @TickerReport
Concert Pharmaceuticals, Inc. $CNCE Stock Rating Lowered by Zacks Investment Research https://t.co/lKSQyWslzR
September 19th 2017, 5:09am
emq_news @emq_news
Concert Pharmaceuticals, Inc. $CNCE Stock Rating Lowered by Zacks Investment Research https://t.co/bcpRIE8HRO
September 19th 2017, 5:09am
CFinancialNews @CFinancialNews
Concert Pharmaceuticals’ $CNCE Buy Rating Reaffirmed at HC Wainwright https://t.co/92TRLmVI1b
September 18th 2017, 10:09pm
intercooleronli @intercooleronli
Concert Pharmaceuticals’ $CNCE Buy Rating Reaffirmed at HC Wainwright https://t.co/qnFC82B5lh
September 18th 2017, 10:09pm
intercooleronli @intercooleronli
Concert Pharmaceuticals, Inc. $CNCE Insider Sells $50,785.00 in Stock https://t.co/fB9LU8KHtQ
September 18th 2017, 8:09pm
dakotafinancial @dakotafinancial
Concert Pharmaceuticals, Inc. $CNCE Insider Sells $50,785.00 in Stock https://t.co/V8Z0J7iwLM
September 18th 2017, 8:09pm
CFinancialNews @CFinancialNews
Concert Pharmaceuticals, Inc. $CNCE Insider Sells $50,785.00 in Stock https://t.co/ExDdFECkwj
September 18th 2017, 8:09pm
WKRBNews @WKRBNews
Somewhat Positive News Coverage Somewhat Unlikely to Affect Concert Pharmaceuticals $CNCE Share Price https://t.co/MQWg6pvFXK
September 18th 2017, 7:09pm
dailypoliticaln @dailypoliticaln
Somewhat Positive News Coverage Somewhat Unlikely to Affect Concert Pharmaceuticals $CNCE Share Price https://t.co/YnfQq0LJMZ
September 18th 2017, 7:09pm
ZolmaxNews @ZolmaxNews
$CNCE - Somewhat Positive News Coverage Somewhat Unlikely to Affect Concert Pharmaceuticals… https://t.co/6gcUgHaXqM
September 18th 2017, 7:09pm
DPolitical @DPolitical
$CNCE - Somewhat Positive News Coverage Somewhat Unlikely to Affect Concert Pharmaceuticals… https://t.co/MvdNya0Olv
September 18th 2017, 7:09pm
dailymailtimes @dailymailtimes
Somewhat Positive News Coverage Somewhat Unlikely to Affect Concert Pharmaceuticals $CNCE Share Price https://t.co/RKc8ebCvRj
September 18th 2017, 7:09pm
midetimes @midetimes
Somewhat Positive News Coverage Somewhat Unlikely to Affect Concert Pharmaceuticals $CNCE Share Price https://t.co/vVCOQbZaOj
September 18th 2017, 7:09pm
CFinancialNews @CFinancialNews
Zacks Investment Research Upgrades Concert Pharmaceuticals, Inc. $CNCE to “Buy” https://t.co/fITuoarzt6
September 18th 2017, 5:09pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.